ImageneBio (IMA) Consolidated Net Income (2020 - 2025)

ImageneBio has reported Consolidated Net Income for 6 years, with the latest figure at -$24.8 million in Q3 2025.

• Quarterly Consolidated Net Income fell 677.66% year-over-year to -$24.8 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$33.6 million (up 33.46% YoY) and the FY2024 annual result came in at -$49.2 million, up 27.77% from the prior year.
• Consolidated Net Income eased to -$24.8 million in Q3 2025 per IMA's latest filing, from -$2.8 million in the prior quarter.
• Over five years, Consolidated Net Income peaked at -$2.8 million in Q2 2025 and troughed at -$2.1 billion in Q2 2022.
• A 5-year average of -$191.6 million and a median of -$17.5 million in 2024 frame the typical range for Consolidated Net Income.
• The sharpest annual moves came in 2022 and 2023: Consolidated Net Income sank 3859.26% in 2022, then soared 99.2% in 2023.
• Over 5 years, Consolidated Net Income stood at -$30.5 million in 2021, then surged by 47.96% to -$15.9 million in 2022, then retreated by 23.9% to -$19.7 million in 2023, then increased by 11.06% to -$17.5 million in 2024, then slumped by 41.62% to -$24.8 million in 2025.
• According to Business Quant data, Consolidated Net Income over the past three periods registered -$24.8 million, -$2.8 million, and -$6.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.